Organon (NYSE: OGN) reported Q2 EPS of $1.25, $0.01 worse than the analyst estimate of $1.26. Revenue for the quarter came in at $1.59 billion versus the consensus estimate of $1.54 billion.

GUIDANCE:

Organon sees FY2022 revenue of $6.1-6.3 billion, versus the consensus of $6.18 billion.

For earnings history and earnings-related data on Organon (OGN) click here.